Discount Code (0% Off) has been applied.
 
Enter a search term.

If you can't find what you were looking for, please contact us using one of the methods below so we can better serve you.

1 (800) 854-7220
answers@mcguff.com Suggest an Item
Hydroxocobalamin (B12) Injection 1000 mcg/mL, Multiple Dose Vial 30 mL, Each
Manufacturer: Teva

Hydroxocobalamin (B12) Injection 1000 mcg/mL, Multiple Dose Vial 30 mL, Each

$61.00
Item Code: 000675
Mfg Part #: 0591-2888-30
This product is only available to licensed healthcare professionals.
Select your shipping method. This is helpful to expedite a portion of your order.
To reduce overall packaging and shipping costs, our shipping department will pack your orders in as few boxes as possible. Compounded drugs must ship separately from our other products. When choosing Next Day or 2nd Day Air shipping methods, final shipping totals will be calculated when your order is packed and invoiced. Box size and package destination does not affect shipping fee calculations. The number of boxes is determined by size, weight and quantity of products ordered. For additional information or questions, please contact us.
  Usually ships within 24 hours.

Hydroxocobalamin Injection, USP is a sterile solution of hydroxocobalamin (vitamin B₁₂) for intramuscular administration. It is indicated for treating vitamin B₁₂ deficiency in conditions such as pernicious anemia, dietary deficiency, and malabsorption syndromes, as well as for use in diagnostic procedures like the Schilling test.

 

Key Benefits:

  • Effective Vitamin B₁₂ Supplementation: Provides essential vitamin B₁₂ to support cellular health, hematopoiesis, and nervous system function.
  • Addresses Pernicious Anemia: Effective for lifelong vitamin B₁₂ replacement in patients with pernicious anemia.
  • Long-Acting Formulation: Provides sustained release, reducing the frequency of injections in long-term management.

 

Dosage and Administration:

For Intramuscular Use Only:

  • Vitamin B₁₂ Deficiency: Initial dose of 30 mcg daily for 5-10 days, followed by a maintenance dose of 100-200 mcg monthly.
  • Schilling Test: Single flushing dose of 1000 mcg. Dosing adjustments may be necessary based on the severity of deficiency and specific patient needs.

 

Why Choose Hydroxocobalamin Injection?

  • Proven Vitamin B₁₂ Replacement: Supports the treatment of anemia and deficiency in cases where oral supplementation is ineffective.
  • Comprehensive Clinical Use: Suitable for a range of deficiency-related conditions, including dietary insufficiency and malabsorption.
  • Convenient Multi-Dose Vial: Offered in a 30 mL vial containing 1000 mcg/mL of hydroxocobalamin.

 

Warnings:

  • Avoid Intravenous Administration: Strictly for intramuscular injection; intravenous use is contraindicated.
  • Hypersensitivity Reactions: Anaphylactic reactions may occur; monitor patients during initial dose administration.
  • Not a Substitute for Folic Acid: Folic acid deficiency may coexist with vitamin B₁₂ deficiency; both may require treatment to avoid masking symptoms.

 

Disclaimer:

This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.

Products specifications
Medical License Required Yes
Class Rx
Product Name Injection
Generic Name Hydroxocobalamin
Route of Administration Intramuscular (IM)
Strength 1,000 mcg/mL
Volume 30 mL
Container Multiple Dose Vial
Feature Sterile
Storage Requirements USP Controlled Room Temperature, Protect from Light
Storage Temperature 20º to 25ºC (68º to 77ºF)
Therapeutic Class Vitamin
Unit of Measure Each

Hydroxocobalamin Injection, USP is a sterile solution of hydroxocobalamin (vitamin B₁₂) for intramuscular administration. It is indicated for treating vitamin B₁₂ deficiency in conditions such as pernicious anemia, dietary deficiency, and malabsorption syndromes, as well as for use in diagnostic procedures like the Schilling test.

 

Key Benefits:

  • Effective Vitamin B₁₂ Supplementation: Provides essential vitamin B₁₂ to support cellular health, hematopoiesis, and nervous system function.
  • Addresses Pernicious Anemia: Effective for lifelong vitamin B₁₂ replacement in patients with pernicious anemia.
  • Long-Acting Formulation: Provides sustained release, reducing the frequency of injections in long-term management.

 

Dosage and Administration:

For Intramuscular Use Only:

  • Vitamin B₁₂ Deficiency: Initial dose of 30 mcg daily for 5-10 days, followed by a maintenance dose of 100-200 mcg monthly.
  • Schilling Test: Single flushing dose of 1000 mcg. Dosing adjustments may be necessary based on the severity of deficiency and specific patient needs.

 

Why Choose Hydroxocobalamin Injection?

  • Proven Vitamin B₁₂ Replacement: Supports the treatment of anemia and deficiency in cases where oral supplementation is ineffective.
  • Comprehensive Clinical Use: Suitable for a range of deficiency-related conditions, including dietary insufficiency and malabsorption.
  • Convenient Multi-Dose Vial: Offered in a 30 mL vial containing 1000 mcg/mL of hydroxocobalamin.

 

Warnings:

  • Avoid Intravenous Administration: Strictly for intramuscular injection; intravenous use is contraindicated.
  • Hypersensitivity Reactions: Anaphylactic reactions may occur; monitor patients during initial dose administration.
  • Not a Substitute for Folic Acid: Folic acid deficiency may coexist with vitamin B₁₂ deficiency; both may require treatment to avoid masking symptoms.

 

Disclaimer:

This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.

Products specifications
Medical License Required Yes
Class Rx
Product Name Injection
Generic Name Hydroxocobalamin
Route of Administration Intramuscular (IM)
Strength 1,000 mcg/mL
Volume 30 mL
Container Multiple Dose Vial
Feature Sterile
Storage Requirements USP Controlled Room Temperature, Protect from Light
Storage Temperature 20º to 25ºC (68º to 77ºF)
Therapeutic Class Vitamin
Unit of Measure Each

Coronavirus (COVID-19)

Due to the Coronavirus (COVID-19) outbreak worldwide, the global demand for some Personal Protective Equipment (PPE) is exceeding current supply availability.

In addition, the manufacturing of the PPE and many other wound care/infection prevention products have been impacted by the global response to the Coronavirus. While you may see product availability reduction in the near-term, please be assured that we at McGuff Medical are continuing to work diligently to ensure an uninterrupted supply of products and alternative products to you.

Additionally, in order to ensure healthcare providers have access to the PPEs they need, the McGuff Company is temporarily limiting PPEs to healthcare providers.

As always, please feel free to reach out to our McGuff Customer Service team with any questions that you may have.

Click here for updates regarding Coronavirus Pandemic and Your Supplies and a message from our President